The business is a SaaS-based technology firm that provides personalized financial technologies to the healthcare industry for use in optimizing patient engagement and payment. The company’s proprietary platform and technology maximize patient payment using individualized financial strategies that lift net revenue, and reduce uncompensated care throughout the $491 billion out-of-pocket spending marketplace. The company is currently partnering with a Fortune 500 financial services firm with the goal to join its payment process capabilities and the company’s core patient financial technology, resulting in the creation of its signature growth initiative which enables healthcare providers to offer and sell their shoppable and non-urgent services directly to consumers online.

Key Aspects

Contracted recurring revenue of nearly $2.2 million annually
Management expects recurring revenue to rise to $2.5 million annually by YE 2022, representing a 46.0% increase when compared to 2021
Average gross profit margin of 71.0% from 2020 through the trailing-twelve-months (TTM) ending June 30, 2022
Recurring revenue client base increased by 69.2% from 2020 through the TTM ending June 30, 2022
As of September 2022, management notes average client lifetime revenue amounting to $753.5k
Exclusive contract with a global financial services firm to commercialize the company’s proprietary ecommerce platform, its signature growth initiative
Client base includes a variety of market and global leaders
Market-governing intellectual property and patented technology with considerable royalty revenue generation potential

Opportunities

Complete development and commercialize the company’s signature ecommerce initiative with a global financial services leader, generating over $160M in projected revenue by 2028
Profit from the projected large increase in the U.S. self-pay marketplace, increasing from $491 billion to over $800 billion by 2026
Complete execution of (and expand upon) the company’s sales pipeline and drive the company’s B2B and B2C profile
Expand the company’s patient affordability technology to the pharmaceutical segment, the healthcare industry more broadly, and direct to consumers
Capitalize on company’s existing patent portfolio to create a new, highly profitable, and recurring royalty revenue stream

Headquartered

United States

Current Markets

The company serves healthcare systems, fintech, billing, digital pay enablement, revenue cycle management, financial consulting, and pharmaceutical industries.

Real Estate

All operations are fully remote, with no office space leased or owned by the company.

Shareholder Objectives

The company’s two co-founders/principals own a majority position of the company (81%). Ownership is seeking a strategic partner to help scale the company and take advantage of its unique growth factors. Both owners wish to remain with the company following a sale.

Benchmark International

Benchmarks Exclusive Opportunities

SaaS-based Healthcare Technology Firm – BN000040015

SaaS-based Healthcare Technology Firm – BN000040015

Login